US5258380A
(en)
*
|
1985-06-24 |
1993-11-02 |
Janssen Pharmaceutica N.V. |
(4-piperidinylmethyl and -hetero)purines
|
NZ223654A
(en)
*
|
1987-03-09 |
1990-03-27 |
Janssen Pharmaceutica Nv |
1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
|
US4943580A
(en)
*
|
1987-03-09 |
1990-07-24 |
Janssen Pharmaceutica N.V. |
Anti-histaminic benzimidazole, imidazopyridine and purine derivatives
|
US5151424A
(en)
*
|
1987-07-01 |
1992-09-29 |
Janssen Pharmaceutica N.V. |
Pharmacologically active (Bicyclic heterocyclyl)methyl and -hetero) substituted hexahydro-1H-azepines and pyrrolidines
|
CA1317939C
(fr)
*
|
1987-07-01 |
1993-05-18 |
Janssen Pharmaceutica Naamloze Vennootschap |
Hexahydro-1h-azepines et pyrrolidines a substitution par des ((heterocyclyle bicyclique) methyle et -hetero
|
US4988689A
(en)
*
|
1987-07-01 |
1991-01-29 |
Janssen Pharmaceutica N.V. |
((Pharmacologically active bicyclic heterocyclic)methyl and -heteroatom) substituted hexahydro-1H-azepines and pyrrolidines
|
GB8716313D0
(en)
*
|
1987-07-10 |
1987-08-19 |
Janssen Pharmaceutica Nv |
2-(heterocyclylalkyl)imidazopyridines
|
GB8900380D0
(en)
*
|
1989-01-09 |
1989-03-08 |
Janssen Pharmaceutica Nv |
2-aminopyrimidinone derivatives
|
PH30434A
(en)
*
|
1989-04-07 |
1997-05-09 |
Janssen Pharmaceutica Nv |
Hydroxyalkylfuranyl derivatives
|
US5272150A
(en)
*
|
1989-04-07 |
1993-12-21 |
Janssen Pharmaceutica N.V. |
Hydroxyalkylfuranyl derivatives
|
US5360807A
(en)
*
|
1990-07-19 |
1994-11-01 |
Janssen Pharmaceutica N.V. |
Substituted thiazolyl and substituted pyridinyl derivatives
|
US5217980A
(en)
*
|
1990-07-19 |
1993-06-08 |
Janssen Pharmaceutica N.V. |
Oxazolyl and piperidinyl substituted benimidazolyl compounds
|
KR100190299B1
(ko)
*
|
1990-07-19 |
1999-06-01 |
디르크 반테 |
신규한 옥사졸릴 유도체
|
NZ238863A
(en)
*
|
1990-07-19 |
1993-03-26 |
Janssen Pharmaceutica Nv |
Substituted thiazolyl and pyridinyl derivatives
|
AU8506791A
(en)
*
|
1990-10-01 |
1992-04-28 |
Janssen Pharmaceutica N.V. |
Novel 4-piperidinylcarbonyl derivatives
|
US5521183A
(en)
*
|
1994-08-30 |
1996-05-28 |
Allergan |
Use of 5-HT ligands as anti-pruritic agents
|
BR9712792A
(pt)
*
|
1996-08-28 |
1999-12-14 |
Procter & Gamble |
Inibidores de metaloprotease bidentada.
|
KR100239800B1
(ko)
*
|
1996-11-28 |
2000-03-02 |
손경식 |
4,5-디아미노 피리미딘 유도체 및 이의 제조방법
|
EP1058684A1
(fr)
*
|
1998-03-06 |
2000-12-13 |
Janssen Pharmaceutica N.V. |
Inhibiteurs du transport de la glycine
|
ES2282386T3
(es)
*
|
2001-02-24 |
2007-10-16 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Derivados de xantina, su preparacion y su uso como medicamentos.
|
AU2002343604C1
(en)
|
2001-10-30 |
2009-09-17 |
Conforma Therapeutics Corporation |
Purine analogs having HSP90-inhibiting activity
|
DE60318826T2
(de)
*
|
2002-03-27 |
2009-01-22 |
Nycomed Gmbh |
Alkoxypyridinderivate
|
JP3675813B2
(ja)
*
|
2002-06-06 |
2005-07-27 |
エーザイ株式会社 |
新規縮合イミダゾール誘導体
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7495005B2
(en)
*
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
US7569574B2
(en)
*
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10238477A1
(de)
*
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10254304A1
(de)
*
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
US7566707B2
(en)
*
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
BRPI0414533A
(pt)
|
2003-09-18 |
2006-11-07 |
Conforma Therapeutics Corp |
composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
|
DE10355304A1
(de)
*
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
US7501426B2
(en)
*
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
DE102004009039A1
(de)
*
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
US7393847B2
(en)
*
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
US7179809B2
(en)
*
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
US7439370B2
(en)
*
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
DE102004043944A1
(de)
*
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004044221A1
(de)
*
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004054054A1
(de)
*
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
KR20080004550A
(ko)
|
2005-03-30 |
2008-01-09 |
콘포마 세러퓨틱스 코포레이션 |
Hsp90-억제제로서 알키닐 피롤로피리미딘 및 관련유사체
|
DE102005035891A1
(de)
*
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
CA2810522A1
(fr)
|
2006-05-04 |
2007-11-15 |
Boehringer Ingelheim International Gmbh |
Polymorphes
|
EP1852108A1
(fr)
*
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Compositions d'inhibiteurs de la DPP IV
|
JP2010500326A
(ja)
*
|
2006-08-08 |
2010-01-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
糖尿病の治療のためのdpp−iv阻害剤としてのピロロ[3,2−d]ピリミジン
|
KR101610005B1
(ko)
*
|
2007-08-17 |
2016-04-08 |
베링거 인겔하임 인터내셔날 게엠베하 |
Fab 관련 질환의 치료에 사용하기 위한 푸린 유도체
|
AR071175A1
(es)
*
|
2008-04-03 |
2010-06-02 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
|
PE20100156A1
(es)
*
|
2008-06-03 |
2010-02-23 |
Boehringer Ingelheim Int |
Tratamiento de nafld
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
BRPI0917675A2
(pt)
*
|
2008-08-15 |
2015-12-01 |
Boehringer Ingelheim Int |
compostos orgânicos para cura de ferida
|
EP2344195A2
(fr)
|
2008-09-10 |
2011-07-20 |
Boehringer Ingelheim International GmbH |
Polythérapie pour le traitement du diabète et des états pathologiques apparentés
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
JP2012512848A
(ja)
|
2008-12-23 |
2012-06-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
有機化合物の塩の形態
|
AR074990A1
(es)
|
2009-01-07 |
2011-03-02 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
|
BR112012012641A2
(pt)
|
2009-11-27 |
2020-08-11 |
Boehringer Ingelheim International Gmbh |
TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA
|
CA2797310C
(fr)
|
2010-05-05 |
2020-03-31 |
Boehringer Ingelheim International Gmbh |
Therapie de combinaison de l'agoniste du recepteur glp-1 et de l'inhibiteur dpp-4
|
AU2011268940B2
(en)
|
2010-06-24 |
2015-05-21 |
Boehringer Ingelheim International Gmbh |
Diabetes therapy
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
US8962636B2
(en)
|
2011-07-15 |
2015-02-24 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP2849755A1
(fr)
|
2012-05-14 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
Dérivé de xanthine en tant qu'inhibiteur de dpp-4 pour l'utilisation dans le traitement de troubles associés aux podocytes et/ou un syndrome néphrotique
|
WO2013174767A1
(fr)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires
|
PL3035936T3
(pl)
|
2013-08-23 |
2019-08-30 |
Neupharma, Inc. |
Pewne jednostki chemiczne, kompozycje i sposoby
|
WO2015128453A1
(fr)
|
2014-02-28 |
2015-09-03 |
Boehringer Ingelheim International Gmbh |
Utilisation médicale d'un inhibiteur de dpp-4
|
EP4233840A3
(fr)
|
2016-06-10 |
2023-10-18 |
Boehringer Ingelheim International GmbH |
Combinaisons de linagliptine et de metformine
|
US10544106B2
(en)
*
|
2016-08-15 |
2020-01-28 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|